Virtus LifeSci Biotech Products ETF Rating $56.81 -0.10 (-0.18%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.77Holdings in BBP have an aggregate rating of Moderate Buy based on 660 analyst ratings issued in the past year covering 50 companies (89.8% of the portfolio).BBP Aggregate Price Target$56.67-0.25% DownsideHigh Prediction$56.67Average Prediction$56.67Low Prediction$56.67Holdings in BBP have an aggregate price target of $56.67 and a range of $56.67 to $56.67 covering 50 companies (89.8% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.51%SAGESage Therapeutics$7.793.5953 of 5 stars2.00$8.81 13.1%19Analyst ForecastNews CoverageGap Up2.43%ONCBeigene$244.90-4.4%3.1627 of 5 stars3.00$318.88 30.2%5Analyst ForecastNews CoverageGap Down2.36%ASNDAscendis Pharma A/S$164.15+2.3%3.1061 of 5 stars2.93$204.67 24.7%15Upcoming EarningsNews CoveragePositive News2.31%BBIOBridgeBio Pharma$36.31+1.0%4.5735 of 5 stars2.92$53.00 46.0%12Upcoming EarningsInsider TradeGap Down2.30%TGTXTG Therapeutics$41.33+2.6%3.389 of 5 stars2.83$40.67 -1.6%6Upcoming EarningsPositive News2.29%HALOHalozyme Therapeutics$60.49+2.1%4.4007 of 5 stars2.60$62.89 4.0%10Analyst ForecastNews Coverage2.18%GILDGilead Sciences$103.17-2.8%4.555 of 5 stars2.79$108.42 5.1%28Earnings ReportAnalyst ForecastAnalyst RevisionPositive NewsGap Down2.12%ZLABZai Lab$32.00-5.3%2.852 of 5 stars2.75$47.37 48.0%4Analyst RevisionNews CoverageGap Up2.09%AXSMAxsome Therapeutics$106.27+0.8%4.576 of 5 stars3.00$169.80 59.8%16Positive News2.07%RYTMRhythm Pharmaceuticals$63.76+1.3%3.8765 of 5 stars3.00$74.92 17.5%13Positive News2.01%ADMAADMA Biologics$21.86-2.1%1.8932 of 5 stars3.25$22.50 2.9%4Positive News1.96%VRTXVertex Pharmaceuticals$493.84+0.3%4.0187 of 5 stars2.64$514.91 4.3%25Analyst ForecastAnalyst RevisionPositive News1.94%PTCTPTC Therapeutics$49.530.0%3.8508 of 5 stars2.53$63.92 29.1%15Analyst ForecastInsider TradeNews Coverage1.93%EXELExelixis$37.43+0.6%4.2988 of 5 stars2.50$37.59 0.4%20Upcoming EarningsPositive News1.91%AMGNAmgen$280.84+0.4%4.6432 of 5 stars2.43$310.57 10.6%23Upcoming EarningsAnalyst ForecastAnalyst RevisionPositive News1.90%KNSAKiniksa Pharmaceuticals$21.37+3.9%2.2058 of 5 stars3.00$37.17 73.9%6Insider Trade1.89%BCRXBioCryst Pharmaceuticals$8.39+2.1%4.2524 of 5 stars2.86$15.57 85.6%71.87%MDGLMadrigal Pharmaceuticals$326.79+2.1%4.4783 of 5 stars3.00$409.00 25.2%9Analyst ForecastPositive News1.85%IMCRImmunocore$30.16-0.7%2.5951 of 5 stars2.54$60.90 101.9%13News CoveragePositive News1.84%INSMInsmed$69.69+1.1%4.1789 of 5 stars3.00$94.00 34.9%16Analyst ForecastOptions VolumeNews CoveragePositive NewsHigh Trading Volume1.83%SWTXSpringWorks Therapeutics$44.72-0.5%2.1876 of 5 stars3.00$73.20 63.7%5Upcoming EarningsNews CoverageHigh Trading Volume1.82%ALNYAlnylam Pharmaceuticals$251.56+3.7%4.5991 of 5 stars2.77$315.58 25.5%26Upcoming EarningsAnalyst UpgradePositive News1.81%TARSTarsus Pharmaceuticals$50.00+0.1%2.1346 of 5 stars3.00$63.67 27.3%7News CoveragePositive News1.78%KRYSKrystal Biotech$168.06-0.6%4.752 of 5 stars3.00$220.00 30.9%8News CoveragePositive News1.77%TBPHTheravance Biopharma$9.75+2.2%1.1441 of 5 stars2.25$11.33 16.2%4News Coverage1.76%LGNDLigand Pharmaceuticals$108.07-0.4%4.4209 of 5 stars3.00$146.43 35.5%7News Coverage1.74%BPMCBlueprint Medicines$87.66+1.8%2.6251 of 5 stars2.70$124.95 42.5%23Upcoming EarningsNews Coverage1.74%LEGNLegend Biotech$34.28+0.1%2.1985 of 5 stars2.92$78.82 129.9%12Analyst ForecastPositive NewsGap Up1.73%MIRMMirum Pharmaceuticals$40.80+0.8%3.9314 of 5 stars3.09$58.20 42.6%11Positive News1.71%HRMYHarmony Biosciences$29.61+0.6%4.6906 of 5 stars3.00$53.33 80.1%9Upcoming EarningsPositive News1.69%BMRNBioMarin Pharmaceutical$63.30+0.9%4.8884 of 5 stars2.71$94.00 48.5%24Upcoming Earnings1.66%ARDXArdelyx$5.26+4.8%4.2659 of 5 stars3.00$10.61 101.7%10Upcoming EarningsNews Coverage1.61%ROIVRoivant Sciences$11.01+0.1%2.4 of 5 stars3.00$17.50 58.9%4Insider TradeNews CoveragePositive NewsGap Up1.61%TVTXTravere Therapeutics$18.33+4.0%2.6151 of 5 stars2.93$32.08 75.0%14Analyst ForecastPositive News1.61%BNTXBioNTech$102.02-15.4%2.4903 of 5 stars2.89$143.44 40.6%18Analyst RevisionHigh Trading Volume1.59%ACADACADIA Pharmaceuticals$14.73-0.7%4.0449 of 5 stars2.50$23.93 62.5%161.59%CRSPCRISPR Therapeutics$38.27-2.1%2.8424 of 5 stars2.48$73.11 91.0%211.58%IBRXImmunityBio$2.61-3.0%1.8944 of 5 stars3.00$12.19 367.0%5Analyst Forecast1.54%DVAXDynavax Technologies$10.82-0.7%4.1486 of 5 stars2.33$20.50 89.5%31.53%INCYIncyte$59.16+0.3%4.8682 of 5 stars2.21$74.69 26.2%19Upcoming Earnings1.52%NBIXNeurocrine Biosciences$106.73+0.9%4.8202 of 5 stars2.86$161.14 51.0%22Upcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage1.51%AUPHAurinia Pharmaceuticals$8.18+1.0%2.5015 of 5 stars3.00$11.50 40.6%2Upcoming EarningsNews CoveragePositive News1.50%UTHRUnited Therapeutics$291.38-1.7%4.9206 of 5 stars2.67$390.17 33.9%12Upcoming EarningsAnalyst ForecastInsider TradePositive News1.47%IONSIonis Pharmaceuticals$29.70+0.4%3.9543 of 5 stars2.70$56.72 91.0%20Upcoming Earnings1.45%REGNRegeneron Pharmaceuticals$602.64+0.5%4.7916 of 5 stars2.88$945.32 56.9%26Upcoming EarningsAnalyst ForecastAnalyst RevisionPositive News1.44%RAREUltragenyx Pharmaceutical$38.09+1.2%4.4708 of 5 stars2.93$92.79 143.6%14Upcoming Earnings1.43%BIIBBiogen$118.84-0.6%4.7633 of 5 stars2.42$211.37 77.9%31Upcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage1.37%AGIOAgios Pharmaceuticals$29.45+0.6%3.8171 of 5 stars2.56$56.57 92.1%9Upcoming Earnings1.34%LXRXLexicon Pharmaceuticals$0.71+0.7%2.751 of 5 stars2.40$3.67 417.6%5Upcoming EarningsGap Up1.27%NVAXNovavax$6.67-5.7%3.6597 of 5 stars2.43$18.00 169.9%7 This page (NYSEARCA:BBP) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBP Stock Free BBP Stock Alerts